Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 6/20 | 0.83 |
| ▸ | ITGA2B | P08514 | 6/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HCRTR2 | O43614 | 5/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.36 |
| ▸ | HCRTR1 | O43613 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CCR3 | P51677 | 1/20 | 0.35 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7986123 | 0.99 | ITGB3 (0.82) | ITGB3ITGA2BKMT2AHCRTR2CA2 | |
| Trifluoroacetic Acid SCHEMBL7989642 | 0.96 | ITGB3 (0.79) | ITGB3ITGA2BKMT2AHCRTR2CA2 | |
| SCHEMBL7989513 | 0.93 | ITGB3 (0.71) | ITGB3ITGA2BKMT2AHCRTR2LMNA | |
| SCHEMBL7989161 | 0.92 | ITGB3 (0.70) | ITGB3ITGA2BKMT2AHCRTR2CA2 | |
| SCHEMBL7986107 | 0.92 | ITGB3 (0.82) | ITGB3ITGA2BKMT2AHCRTR2CA2 | |
| SCHEMBL7975092 | 0.92 | ITGB3 (0.70) | ITGB3ITGA2BKMT2AHCRTR2CA2 | |
| SCHEMBL7975126 | 0.92 | ITGB3 (0.79) | ITGB3ITGA2BKMT2AHCRTR2CA2 | |
| SCHEMBL7986765 | 0.92 | ITGB3 (0.69) | ITGB3ITGA2BKMT2AHCRTR2CA2 | |
| SCHEMBL7989233 | 0.91 | ITGB3 (0.69) | ITGB3ITGA2BKMT2AHCRTR2HCRTR1 | |
| SCHEMBL7986245 | 0.91 | ITGB3 (0.69) | ITGB3ITGA2BHCRTR2LMNAHCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6306880-B1 | HETEROCYCLIC ALCOHOL DERIVATIVES AS FUNGICIDES | SANKYO COMPANY, LIMITED (JP) | 2001-10-23 | — | — | US | disclosed |
| US-20010031768-A1 | Triazole antifungal agent | SANKYO COMPANY LIMITED (JP) | 2001-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010031768-A1 | Triazole antifungal agent | ERG28, RIF1, NAT1 | ITGB3 2885/4885ITGA2B 4105/4885KMT2A 1099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.